Dean J Mitchell - Net Worth and Insider Trading
Dean J Mitchell Net Worth
The estimated net worth of Dean J Mitchell is at least $1 Million dollars as of 2024-11-13. Dean J Mitchell is the Director of Praxis Precision Medicines Inc and owns about 5,000 shares of Praxis Precision Medicines Inc (PRAX) stock worth over $415,225. Dean J Mitchell is the Director of Precigen Inc and owns about 356,836 shares of Precigen Inc (PGEN) stock worth over $335,925. Dean J Mitchell is also the Director of Immunogen Inc and owns about 10,000 shares of Immunogen Inc (IMGN) stock worth over $312,300. Details can be seen in Dean J Mitchell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dean J Mitchell has not made any transactions after 2023-09-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dean J Mitchell
Dean J Mitchell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dean J Mitchell owns 6 companies in total, including Praxis Precision Medicines Inc (PRAX) , Immunogen Inc (IMGN) , and Precigen Inc (PGEN) among others .
Click here to see the complete history of Dean J Mitchell’s form 4 insider trades.
Insider Ownership Summary of Dean J Mitchell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRAX | Praxis Precision Medicines Inc | 2023-03-24 | director |
| IMGN | Immunogen Inc | 2019-09-30 | director |
| PGEN | Precigen Inc | 2023-09-22 | director |
 | | 2014-06-03 | director |
| | 2003-09-10 | President & U.S. Primary Care |
| | 2020-12-02 | director |
Dean J Mitchell Latest Holdings Summary
Dean J Mitchell currently owns a total of 3 stocks. Among these stocks, Dean J Mitchell owns 5,000 shares of Praxis Precision Medicines Inc (PRAX) as of March 24, 2023, with a value of $415,225 and a weighting of 39.05%. Dean J Mitchell owns 356,836 shares of Precigen Inc (PGEN) as of September 22, 2023, with a value of $335,925 and a weighting of 31.59%. Dean J Mitchell also owns 10,000 shares of Immunogen Inc (IMGN) as of November 17, 2015, with a value of $312,300 and a weighting of 29.37%.
Latest Holdings of Dean J Mitchell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRAX | Praxis Precision Medicines Inc | 2023-03-24 | 5,000 | 83.05 | 415,225 |
| PGEN | Precigen Inc | 2023-09-22 | 356,836 | 0.94 | 335,925 |
| IMGN | Immunogen Inc | 2015-11-17 | 10,000 | 31.23 | 312,300 |
Holding Weightings of Dean J Mitchell
Dean J Mitchell Form 4 Trading Tracker
According to the SEC Form 4 filings, Dean J Mitchell has made a total of 2 transactions in Praxis Precision Medicines Inc (PRAX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Praxis Precision Medicines Inc is the acquisition of 3,333 shares on March 24, 2023, which cost Dean J Mitchell around $42,000.
According to the SEC Form 4 filings, Dean J Mitchell has made a total of 1 transactions in Precigen Inc (PGEN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Precigen Inc is the acquisition of 25,000 shares on September 22, 2023, which cost Dean J Mitchell around $35,250.
According to the SEC Form 4 filings, Dean J Mitchell has made a total of 0 transactions in Immunogen Inc (IMGN) over the past 5 years. The most-recent trade in Immunogen Inc is the acquisition of 10,000 shares on November 17, 2015, which cost Dean J Mitchell around $125,100.
Insider Trading History of Dean J Mitchell
- 1
Dean J Mitchell Trading Performance
GuruFocus tracks the stock performance after each of Dean J Mitchell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dean J Mitchell is 8.19%. GuruFocus also compares Dean J Mitchell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dean J Mitchell within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dean J Mitchell's insider trading performs compared to the benchmark.
Performance of Dean J Mitchell
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.26 | | | | | |
| Relative Return to S&P 500(%) | 19.62 | | | | | |
Dean J Mitchell Ownership Network
Ownership Network List of Dean J Mitchell
Ownership Network Relation of Dean J Mitchell
Dean J Mitchell Owned Company Details
What does Praxis Precision Medicines Inc do?
Who are the key executives at Praxis Precision Medicines Inc?
Dean J Mitchell is the director of Praxis Precision Medicines Inc. Other key executives at Praxis Precision Medicines Inc include Chief Executive Officer Marcio Souza , Chief Financial Officer Timothy Edwin Kelly , and Principal Accounting Officer Lauren Mastrocola .
Praxis Precision Medicines Inc (PRAX) Insider Trades Summary
Over the past 18 months, Dean J Mitchell made no insider transaction in Praxis Precision Medicines Inc (PRAX). Other recent insider transactions involving Praxis Precision Medicines Inc (PRAX) include a net purchase of 14,500 shares made by Jill Desimone , and a net purchase of 10,000 shares made by Marcio Souza .
In summary, during the past 3 months, insiders sold 0 shares of Praxis Precision Medicines Inc (PRAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Praxis Precision Medicines Inc (PRAX) were sold and 1,633 shares were bought by its insiders, resulting in a net purchase of 1,633 shares.
Praxis Precision Medicines Inc (PRAX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Praxis Precision Medicines Inc Insider Transactions
Dean J Mitchell Mailing Address
Above is the net worth, insider trading, and ownership report for Dean J Mitchell. You might contact Dean J Mitchell via mailing address: C/o Bristol Myers Squibb Co, 345 Park Ave, New York Ny 10164.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
